Listen "The Future of Psychedelic Therapy Research for Clinical and Non-Clinical Use | Andrew Penn"
Episode Synopsis
Learn what’s to come in psychedelic therapy research including risk mitigation, contraindications, and treatment purposes as Andrew Penn explores this important subject.Episode SummaryIn this conversation, Andrew Penn, co-founder of the Organization of Psychedelic and Entheogenic Nurses (OPENurses), discusses the use of psychedelics in therapy and the challenges and concerns surrounding this emerging field. He addresses psychedelic misconceptions and hype, emphasizing the need for more research and caution. He also explores the potential benefits and risks of psychedelic retreats as well as the importance of psychedelic harm reduction. Penn highlights the specific considerations for using psychedelics in individuals with bipolar disorder and the need for further study in this area. Additionally, he discusses the potential impact of hormonal factors on psychedelic therapy and the recent approval of a treatment for postpartum depression. This conversation explores the manifestation of depression, contraindications for psychedelic use, serotonin syndrome, and the future of psychedelics.Discussed in this episode: The need for psychedelic therapy research to separate the hype from the realityHarm reduction strategies, such as safe spaces and support, in the use of psychedelicsRisks of bipolar disorder and psychedelics and the careful considerations to understandInteractions between psychedelics and hormones and the need for more researchThe recent approval of a treatment for postpartum depression in mental health careContraindications for psychedelic use, including a history of psychosis, cardiovascular disorders, and certain medicationsThe dangers of serotonin syndrome that can occur from the over-use of psychedelics The use of psychedelics in clinical vs. non-clinical settings "One myth to unpack is this idea that [psychedelic use] is ‘one and done’ and ‘curative.’ And frankly, I was part of that hype at the beginning, too, because in our very early studies, that's what we were starting to see." - Andrew PennRelated to this episode:Resources and episodes on Mental Health Listen to the series on Psychedelic-Assisted TherapyLearn more about the Organization of Psychedelic and Entheogenic NursesStay in touch with Andrew Penn on his website and LinkedIn.Check out Unseen Women in Psychedelic History by Maria Mangini🎧 Loved the episode? Here's how you can take action:1. Help others discover Fempower Health:Leave a quick review on Apple or Spotify. It’s the easiest way to support our mission and amplify women’s health voices.2. Stay connected:Follow us on LinkedIn, Instagram and
ZARZA We are Zarza, the prestigious firm behind major projects in information technology.